Ovid Therapeutics (OVID) Revenue (2020 - 2025)
Ovid Therapeutics (OVID) reported Revenue of $718000.0 for Q4 2025, up 844.74% on a YoY basis from $76000.0 in Q4 2024, and up 443.94% quarter-over-quarter from $132000.0 in Q3 2025.
Ovid Therapeutics (OVID) Revenue (2020 - 2025) Analysis & Trends
Ovid Therapeutics has reported Revenue for 6 years, with the latest figure at $718000.0 in Q4 2025.
- For the quarter ending Q4 2025, Revenue rose 844.74% year-over-year to $718000.0; the trailing twelve-month figure through Mar 2026 stood at $7.1 million (up 1199.64% YoY), and the FY2025 full-year result was $7.3 million, up 1181.27% from the prior year.
- Revenue for Q4 2025 stood at $718000.0, up from $132000.0 in the prior quarter.
- The five-year high for Revenue was $208.4 million in Q1 2021, with the low at $11102.0 in Q3 2022.
- Historically, Revenue has averaged $13.6 million across 5 years, with a median of $137000.0 in 2023.
- Annual changes were most pronounced in 2022 — Revenue tumbled 99.57% — and 2025, when it soared 3611.24%.
- Ovid Therapeutics' Revenue stood at $208.4 million in 2021, then sank by 99.98% to $46280.0 in 2022, then jumped by 206.83% to $142000.0 in 2023, then slumped by 46.48% to $76000.0 in 2024, then jumped by 844.74% to $718000.0 in 2025.
- The last three Revenue figures came in at $718000.0 (Q4 2025), $132000.0 (Q3 2025), and $6.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ovid Therapeutics | 311.83 Mn | 156.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 718,000.00 |
| Sep 30, 2025 | 132,000.00 |
| Jun 30, 2025 | 6.27 Mn |
| Mar 31, 2025 | 130,000.00 |
| Dec 31, 2024 | 76,000.00 |
| Sep 30, 2024 | 173,000.00 |
| Jun 30, 2024 | 169,000.00 |
| Mar 31, 2024 | 148,000.00 |
| Dec 31, 2023 | 142,000.00 |
| Sep 30, 2023 | 109,000.00 |
| Jun 30, 2023 | 75,000.00 |
| Mar 31, 2023 | 66,000.00 |
| Dec 31, 2022 | 46,280.00 |
| Sep 30, 2022 | 11,102.00 |
| Mar 31, 2022 | 900,000.00 |
| Mar 31, 2021 | 208.38 Mn |
| Dec 31, 2020 | 5.70 Mn |
| Sep 30, 2020 | 6.91 Mn |